Insider Transactions in Q3 2021 at Rapt Therapeutics, Inc. (RAPT)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
9,239
-100.0%
|
$314,126
$34.8 P/Share
|
|
Sep 27
2021
|
Column Group Ii, LP > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
9,239
+50.0%
|
$212,497
$23.26 P/Share
|
|
Sep 20
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-3.07%
|
$80,000
$40.0 P/Share
|
|
Sep 17
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-0.62%
|
$76,000
$38.92 P/Share
|
|
Sep 15
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,535
-86.39%
|
$1,240,795
$37.45 P/Share
|
|
Sep 14
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
147,676
-44.56%
|
$5,316,336
$36.63 P/Share
|
|
Sep 13
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,317
-7.98%
|
$501,095
$35.27 P/Share
|
|
Sep 10
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,738
-10.69%
|
$760,830
$35.19 P/Share
|
|
Sep 10
2021
|
Column Group Ii, LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
497,048
+46.13%
|
-
|
|
Sep 10
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
279,710
-100.0%
|
-
|
|
Sep 10
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,166,666
-45.42%
|
-
|
|
Sep 10
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,648
-11.79%
|
$92,680
$35.78 P/Share
|
|
Sep 10
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,648
+10.55%
|
$15,888
$6.18 P/Share
|
|
Sep 08
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-4.4%
|
$108,000
$36.04 P/Share
|
|
Sep 02
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,101
-100.0%
|
$1,298,535
$35.43 P/Share
|
|
Sep 01
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
31,749
-26.45%
|
$1,111,215
$35.23 P/Share
|
|
Aug 24
2021
|
Wendye Robbins |
BUY
Open market or private purchase
|
Indirect |
525
+10.72%
|
$15,750
$30.91 P/Share
|
|
Aug 24
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,867
-27.89%
|
$708,877
$31.31 P/Share
|
|
Aug 23
2021
|
Wendye Robbins |
BUY
Open market or private purchase
|
Indirect |
1,475
+28.31%
|
$45,725
$31.42 P/Share
|
|
Aug 23
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
68,340
-18.76%
|
$2,118,540
$31.57 P/Share
|
|
Aug 20
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,539
-3.04%
|
$136,170
$30.08 P/Share
|
|
Aug 20
2021
|
Wendye Robbins |
BUY
Open market or private purchase
|
Direct |
600
+3.43%
|
$17,400
$29.65 P/Share
|
|
Aug 18
2021
|
Column Group Ii, LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
373,090
+50.0%
|
-
|
|
Aug 18
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
208,403
-100.0%
|
-
|
|
Aug 18
2021
|
Column Group Ii, LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,317,005
-33.89%
|
-
|
|
Aug 16
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-1.45%
|
$32,000
$32.07 P/Share
|
|
Aug 11
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,647
-11.79%
|
$82,057
$31.19 P/Share
|
|
Aug 11
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,647
+10.54%
|
$15,882
$6.18 P/Share
|
|
Aug 06
2021
|
William Ho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,690
+5.07%
|
$44,280
$12.0 P/Share
|
|
Aug 04
2021
|
William Ho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
694
+0.53%
|
$4,164
$6.24 P/Share
|
|
Aug 02
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-1.52%
|
$30,000
$30.52 P/Share
|
|
Jul 23
2021
|
William Ho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,193
+6.01%
|
$49,158
$6.24 P/Share
|
|
Jul 15
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-1.71%
|
$30,000
$30.23 P/Share
|
|
Jul 12
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,648
-11.79%
|
$87,384
$33.53 P/Share
|
|
Jul 12
2021
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,648
+10.55%
|
$15,888
$6.18 P/Share
|
|
Jul 07
2021
|
Wendye Robbins |
BUY
Open market or private purchase
|
Direct |
1,000
+6.19%
|
$30,000
$30.18 P/Share
|
|
Jul 01
2021
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-1.68%
|
$31,000
$31.75 P/Share
|